tiprankstipranks
Trending News
More News >

Mayne Pharma Initiates Trading Halt Amid Acquisition Talks

Story Highlights
Mayne Pharma Initiates Trading Halt Amid Acquisition Talks

Confident Investing Starts Here:

An announcement from Mayne Pharma Group ( (AU:MYX) ) is now available.

Mayne Pharma Group Limited has requested a trading halt on its securities pending a significant announcement regarding a proposed acquisition by Cosette through a scheme of arrangement. This move indicates a strategic shift that could impact the company’s market positioning and stakeholder interests, as the trading halt will remain until the announcement is made or normal trading resumes.

The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.

More about Mayne Pharma Group

Mayne Pharma Group Limited is a pharmaceutical company that specializes in the development and manufacturing of branded and generic pharmaceutical products. The company focuses on providing innovative solutions in the healthcare industry, catering to a diverse market with a range of therapeutic offerings.

YTD Price Performance: 30.38%

Average Trading Volume: 904,112

Technical Sentiment Signal: Buy

Current Market Cap: A$526.5M

Find detailed analytics on MYX stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1